The SchrOedinger Building
Oxford Science Park
Oxford OX4 4GE
United Kingdom
44 18 6581 8941
https://www.exscientia.ai
Sector(s):Â Healthcare
Industry:Â Biotechnology
Full Time Employees:Â 285
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Prof. Andrew L. Hopkins DPHIL, FRSE FRSC | Founder, CEO & Exec. Director | N/A | N/A | 1973 |
Mr. Ben Ashwell-Fryer | VP of Fin. | N/A | N/A | N/A |
Mr. Ben R. Taylor | CFO, Chief Strategy Officer & Exec. Director | N/A | N/A | 1977 |
Ms. Heather Togwell | Operations Mang. | N/A | N/A | N/A |
Dr. David Hallett Ph.D. | Chief Operating Officer | N/A | N/A | 1971 |
Dr. Garry Pairaudeau Ph.D. | Chief Technology Officer | N/A | N/A | 1967 |
Ms. Eileen Jennings-Brown | Chief Information Officer | N/A | N/A | N/A |
Ms. Sara Sherman | VP of Investor Relations | N/A | N/A | N/A |
Mr. Dan Ireland | VP of Legal | N/A | N/A | N/A |
Ms. Amanda Galgay | VP of Communications | N/A | N/A | N/A |
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Exscientia plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.